Astrazeneca plc ADR (NASDAQ: AZN) Loses -24.00% From High. Why That Could Change?
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of 0.60% and -13.32% over the past three months. AZN shares are trading -1.07% year to date (YTD), with the 12-month market performance up to 0.50% higher. […]
Uncovering Institutional Buying In Astrazeneca plc ADR (NASDAQ: AZN)
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of 0.00% and -14.51% over the past three months. AZN shares are trading -0.25% year to date (YTD), with the 12-month market performance up to 3.67% higher. […]
Investors Should Take Note Of Astrazeneca plc ADR (AZN)
Astrazeneca plc ADR (AZN) concluded trading on Wednesday at a closing price of $67.40, with 7.07 million shares of worth about $476.64 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -15.82% during that period and on December 11, 2024 the price saw a […]
Tomorrow Is Not Likely To Be Same For Astrazeneca plc ADR (AZN)
Astrazeneca plc ADR (AZN) concluded trading on Wednesday at a closing price of $66.78, with 5.07 million shares of worth about $338.28 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -16.86% during that period and on December 04, 2024 the price saw a […]
Are Analysts Expecting A Better 2020 For Astrazeneca plc ADR (AZN)?
Astrazeneca plc ADR (AZN) concluded trading on Thursday at a closing price of $67.20, with 4.18 million shares of worth about $281.04 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -12.47% during that period and on November 28, 2024 the price saw a […]
Astrazeneca plc ADR (NASDAQ: AZN): Do Not Miss The Gain Train
Astrazeneca plc ADR (AZN) concluded trading on Wednesday at a closing price of $72.83, with 8.23 million shares of worth about $599.28 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -4.69% during that period and on October 30, 2024 the price saw a […]
Institutional Exposure To Astrazeneca plc ADR (AZN)
Astrazeneca plc ADR (AZN) concluded trading on Thursday at a closing price of $75.90, with 2.69 million shares of worth about $203.82 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.16% during that period and on October 24, 2024 the price saw a […]
Is Astrazeneca plc ADR (NASDAQ: AZN) Proving The Doubters Wrong?
Astrazeneca plc ADR (AZN) concluded trading on Wednesday at a closing price of $78.31, with 3.23 million shares of worth about $252.92 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 14.27% during that period and on October 16, 2024 the price saw a […]
Handle With Care: Astrazeneca plc ADR (NASDAQ: AZN)
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of -2.11% and -3.61% over the past three months. AZN shares are trading 14.14% year to date (YTD), with the 12-month market performance up to 13.33% higher. […]
Astrazeneca plc ADR (NASDAQ: AZN): Hunting Genuine Value In Market Debris
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of 5.91% and 1.94% over the past three months. AZN shares are trading -3.43% year to date (YTD), with the 12-month market performance down to -4.28% lower. […]
